Search Results - "Ferreira, Luís Carlos Souza"
-
1
Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action
Published in PloS one (27-01-2014)“…Bacillus subtilis spores have received growing attention regarding potential biotechnological applications, including the use as probiotics and in vaccine…”
Get full text
Journal Article -
2
Streptococcus mutans glutamate binding protein (GlnH) as antigen target for a mucosal anti-caries vaccine
Published in Brazilian journal of microbiology (01-12-2022)“…Background In recent years, several studies have demonstrated that bacterial ABC transporters present relevant antigen targets for the development of vaccines…”
Get full text
Journal Article -
3
Strain-specific transcriptional and posttranscriptional regulation of heat-labile toxin expression by enterotoxigenic Escherichia coli
Published in Brazilian journal of microbiology (01-06-2020)“…Enterotoxigenic Escherichia coli (ETEC) represents one of the most important etiological agents of diarrhea in developing countries and characteristically…”
Get full text
Journal Article -
4
Association of high pressure and alkaline condition for solubilization of inclusion bodies and refolding of the NS1 protein from zika virus
Published in BMC biotechnology (12-12-2018)“…Proteins in inclusion bodies (IBs) present native-like secondary structures. However, chaotropic agents at denaturing concentrations, which are widely used for…”
Get full text
Journal Article -
5
Modulating APOBEC expression enhances DNA vaccine immunogenicity
Published in Immunology and cell biology (01-11-2015)“…DNA vaccines have failed to induce satisfactory immune responses in humans. Several mechanisms of double‐stranded DNA (dsDNA) sensing have been described, and…”
Get full text
Journal Article -
6
NS1-based ELISA test efficiently detects dengue infections without cross-reactivity with Zika virus
Published in International journal of infectious diseases (01-11-2021)“…•Dengue virus (DENV) recombinant ΔNS1 proteins preserve immune dominant B-cell epitopes.•ΔNS1 shows reduced cross-reactivity with anti-Zika virus (ZIKV)…”
Get full text
Journal Article -
7
Immunization with a recombinant BibA surface protein confers immunity and protects mice against group B Streptococcus (GBS) vaginal colonization
Published in Vaccine (14-07-2020)“…•Recombinant GBS-V BibA induced local and systemic immune responses in immunized mice.•BibA-specific antibodies reduced GBS-V invasion and increased the…”
Get full text
Journal Article -
8
Specificity of NS1-based immunochromatographic tests for dengue virus with regard to the Zika virus protein
Published in International journal of infectious diseases (01-06-2020)“…This study was performed to determine whether Dengue virus (DENV) immunochromatographic tests can detect and differentiate nonstructural protein 1 (NS1) from…”
Get full text
Journal Article -
9
Adverse events of vaccines and the consequences of non-vaccination: a critical review
Published in Revista de saúde pública (01-01-2018)“…To analyze the risks related to vaccines and the impacts of non-vaccination on the world population. This is a narrative review that has considered information…”
Get full text
Journal Article -
10
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
Published in Molecular therapy (08-07-2020)“…Influenza viruses are respiratory pathogens of public health concern worldwide with up to 650,000 deaths occurring each year. Seasonal influenza virus vaccines…”
Get full text
Journal Article -
11
LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1
Published in Vaccine (19-12-2017)“…In this study, we evaluated the immunogenicity, protective efficacy and peptide-based immune signatures of antibodies raised in mice after sublingual…”
Get full text
Journal Article -
12
Layer-by-Layer Assembly of Polymeric Nanoparticles with Heparin-RBD Complexes as an Adjuvant for SARS-CoV‑2 Protein-Based Vaccines
Published in ACS applied nano materials (23-02-2024)“…Multilayered polymeric particles work as carriers of compounds with controlled release triggered by the layer’s disassembly, allowing chemical stability along…”
Get full text
Journal Article -
13
Optimization and scale-up production of Zika virus ΔNS1 in Escherichia coli: application of Response Surface Methodology
Published in AMB Express (31-12-2019)“…Diagnosing Zika virus (ZIKV) infections has been challenging due to the cross-reactivity of induced antibodies with other flavivirus. The concomitant…”
Get full text
Journal Article -
14
CpG Oligodeoxinucleotides and Flagellin Modulate the Immune Response to Antigens Targeted to CD8α + and CD8α - Conventional Dendritic Cell Subsets
Published in Frontiers in immunology (04-12-2017)“…Dendritic cells (DCs) are antigen-presenting cells essential for the induction of adaptive immune responses. Their unprecedented ability to present antigens to…”
Get full text
Journal Article -
15
A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice
Published in PloS one (13-09-2012)“…Dengue virus (DENV) is the causative agent of dengue fever (DF), a mosquito-borne illness endemic to tropical and subtropical regions. There is currently no…”
Get full text
Journal Article -
16
The Anti-Dengue Virus Peptide DV2 Inhibits Zika Virus Both In Vitro and In Vivo
Published in Viruses (25-03-2023)“…The C-terminal portion of the E protein, known as stem, is conserved among flaviviruses and is an important target to peptide-based antiviral strategies. Since…”
Get full text
Journal Article -
17
Design, Immune Responses and Anti-Tumor Potential of an HPV16 E6E7 Multi-Epitope Vaccine
Published in PloS one (21-09-2015)“…Cervical cancer is a common type of cancer among women worldwide and infection with high-risk human papillomavirus (HPVs) types represents the major risk…”
Get full text
Journal Article -
18
Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen
Published in Clinical and vaccine immunology (01-06-2016)“…Dengue fever is caused by any of the four known dengue virus serotypes (DENV1 to DENV4) that affect millions of people worldwide, causing a significant number…”
Get full text
Journal Article -
19
Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein
Published in Frontiers in immunology (25-09-2017)“…The heat-labile toxins (LT) produced by enterotoxigenic display adjuvant effects to coadministered antigens, leading to enhanced production of serum…”
Get full text
Journal Article -
20
Nanovaccine based on self-assembling nonstructural protein 1 boosts antibody responses to Zika virus
Published in Nanomedicine (01-02-2021)“…Self-assembling proteins may be generated after the addition of short specific amino acid sequences at both the N- and C-terminal ends. To date, this approach…”
Get full text
Journal Article